BioSpace News Archive

2seventy bio, Inc., a leading immuno-oncology cell therapy company, announced that the Phase 1 trial of the PLAT-08 study of SC-DARIC33 in Acute Myeloid Leukemia has been paused by Seattle Children’s, the Company’s partner and the regulatory sponsor of the study.

HCW Biologics Inc. was granted U.S. Patent No. 11,672,826 on June 13, 2023, which contains methods of use claims directed to administering the Company’s clinical-stage bifunctional immunotherapeutic, HCW9218, to treat cancer, including colorectal cancer, breast cancer, ovarian cancer, hepatocellular carcinoma, gastric cancer, urothelial carcinoma, and melanoma.

Blue Water Biotech, Inc., a biotechnology company spanning multiple sectors, announced the signing of an Asset Purchase Agreement with WraSer, LLC and Xspire Pharma, LLC for the purchase of six FDA-approved assets across multiple indications, including cardiology, otic infections, and pain management.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies, announced it has received U.S. Food and Drug Administration 510 clearance for its Pounce™ LP Thrombectomy System.

NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) (“NLS” or the “Company”) today announced positive data from five recently completed in vitro drug-drug interaction studies investigating the potential for DDI of mazindol, a triple monoamine reuptake inhibitor and partial orexin-2 agonist, as well as its hydrolyzed metabolite (M6).

Aspen Neuroscience, Inc. co-founder and Senior Vice President, Research & Development, Andrés Bratt-Leal, PhD, will present “Enabling Autologous iPSC-Derived Cell Therapies with Predictive Genomics,” during the Focus Sessions taking place during this week’s 2023 International Society for Stem Cell Research Annual Meeting in Boston, Mass.

Spero Therapeutics, Inc. announced that Satyavrat “Sath” Shukla, Spero’s current Chief Financial Officer and Treasurer, will serve as Spero’s President and Chief Executive Officer, and as a member of the Board of Directors, effective August 1, 2023.

Avadel Pharmaceuticals plc, a company focused on transforming medicines to transform lives, announced leader sponsorship of the American Academy of Sleep Medicine Foundation’s 15th Annual Young Investigators Research Forum.

Aprea Therapeutics, Inc. announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Maxim Virtual Healthcare Conference, being held online from June 20–June 22, 2023.

Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, announced that its Chief Financial Officer, Eric T. Schmidt, Ph.D., will step down from his position to spend more time with his family on the East Coast.